Tumour necrosis factor-alpha (TNFα) stimulates the growth of human bone marrow stromal cells

Mediators of Inflammation

Volumn 6, Issue 3, 1997, Pages 233-235

  Rougier, F ^a   Cornu, E ^b   Gachard, N ^a   Praloran, V ^a   Denizot, Y ^a  

^a UNIVERSITY OF LIMOGES   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Cytokines; Growth; Marrow stromal cells; Tumour necrosis factor

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MITOGENIC AGENT; STEM CELL FACTOR; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATION; MYELOFIBROSIS; PRIORITY JOURNAL; STROMA CELL;

EID: 0030877146     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359791730     Document Type: Article

References (12)

1. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1995; 49: 225-233.
2. Rougier F, Dupuis F, Denizot Y. Human bone marrow fibroblasts - an overview of their characterization, proliferation and inflammatory mediator production. Hematol Cell Ther 1996; 38: 241-246.
3. Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Ann Rev Immunol 1990; 8: 111-137.
4. Moreau I, Duvert V, Caux C, et al. Myofibroblastic stromal cells isolated from human bone marrow induce the proliferation of both early myeloid and B-lymphoid cells. Blood 1993; 82: 2396-2405.
5. Fiers W. Tumor necrosis factor. Characterization at the molecular. cellular and in vivo level. FEBS Lett 1991; 285: 199-212.
6. Ulich TR, Shin SS, del Castillo J. Haematologic effects of TNF. Res Immunol 1993; 144: 347-354.
7. Battegay EJ, Raines EW, Colbert T, Ross R. TNF-α stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol 1995; 154: 6040-6047.
8. Cao X, Guy GR, Sukhatme VP, Tan YH. Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. J Biol Chem 1992; 267: 1345-1349.
9. Siegel SA, Shealy DJ, Nakada MT, et al. The mouse/human chimeric monoclonal antibody cA2 neutralizes in vitro and protects transgenic mice from cachexia and TNF leathality in vivo. Cytokine 1995; 7: 15-25.
10. Denizot Y, Rougier F, Dupuis F, et al. PAF and haematopoiesis. VIII. Biosynthesis and metabolism of platelet-activating factor by human bone marrow stromal cells. Exp Hematol 1996; 24: 1327-1332.
11. Lorgeot V, Trimoreau F, Gachard N, Praloran V, Denizot Y. Leukemia inhibitory factor (LIF) concentrations in the bone marrow plasma of patients with hematologic malignancies. Eur Cytokine Netw 1977; 8: 57-59.
12. Baud L, Perez J, Denis M, Ardaillou R. 1987. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: Effect of indomethacin. J Immunol 1987; 138: 1190-1195.